Market research
PGNY Progyny Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2B
- P/E ratio
- 28.07
- Analyst target
- 34.25
- Dividend yield
- Not available
- Beta
- 1.02
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Healthcare Plans
- ISIN
- US74340E1038
- Market cap
- 2B
- P/E ratio
- 28.07
- Analyst target
- 34.25
- Dividend yield
- Not available
- Beta
- 1.02
About
About Progyny Inc
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the PGNY discussion.
5 years, 4 months ago
Progyny, Inc is currently in a long term uptrend where the price is trading 35.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.1.
Progyny, Inc's total revenue rose by 54.0% to $100M since the same quarter in the previous year.
Its net income has increased by 983.2% to $39M since the same quarter in the previous year.
Finally, its free cash flow grew by 182.9% to $6M since the same quarter in the previous year.
Based on the above factors, Progyny, Inc gets an overall score of 5/5.